We are live on ! Find out more

First Trust NYSE Arca Biotechnology Index Fund

FBT

Market cap $2.98B

273.36 USD

+0.50

0.18%

At close Updated Sep 28, 4:00 PM EDT

1 day

0.18%

5 days

0.96%

1 month

2.4%

3 months

10.39%

6 months

41.64%

Year to date

31.59%

1 year

54.59%

5 years

64.34%

10 years

169.83%

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 15.4%

Neutral 76.9%

Negative 7.7%

Zacks Investment Research

Biotech ETFs to Buy as Cancer Drug Breakthroughs Accelerate

Biotech ETFs offer diversified exposure to oncology innovation as cancer funding surges and the global oncology drug market expands.

Biotech ETFs to Buy as Cancer Drug Breakthroughs Accelerate

Zacks Investment Research

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?

A smart beta exchange traded fund, the First Trust NYSE Arca Biotechnology ETF (FBT) debuted on 06/19/2006, and offers broad exposure to the Health Care ETFs category of the market.

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?

Zacks Investment Research

Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?

Launched on June 19, 2006, the First Trust NYSE Arca Biotechnology ETF (FBT) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market.

Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?

The Motley Fool

XBI vs. FBT: Broad Biotech Exposure or Concentrated Bets?

State Street SPDR S&P Biotech ETF carries a lower expense ratio of 0.35% compared to First Trust NYSE Arca Biotechnology Index Fund. FBT maintains a highly concentrated portfolio of only 30 holdings, while XBI spans 155 companies.

XBI vs. FBT: Broad Biotech Exposure or Concentrated Bets?

The Motley Fool

IYH vs. FBT: Broad Healthcare ETF or Concentrated Biotech Play?

The iShares U.S. Healthcare ETF provides broad sector exposure with 100 holdings, while the First Trust NYSE Arca Biotechnology Index Fund focuses on a concentrated basket of 30 biotech stocks. The First Trust fund has delivered higher recent returns but experiences greater price volatility.

IYH vs. FBT: Broad Healthcare ETF or Concentrated Biotech Play?

The Motley Fool

State Street vs. First Trust: Is a Broad Healthcare or Biotech Focus Better for Your Portfolio?

State Street Health Care Select Sector SPDR ETF offers a significantly lower expense ratio of 0.08% compared to the 0.55% charged by First Trust NYSE Arca Biotechnology Index Fund. First Trust's fund focuses exclusively on 30 biotechnology companies, while the SPDR ETF holds 60 stocks across the broader healthcare sector.

State Street vs. First Trust: Is a Broad Healthcare or Biotech Focus Better for Your Portfolio?

24/7 Wall Street

FBT and IBB Are Not the Same Biotech Bet, and 5 Years of Returns Prove It

Biotech investors picking between the First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) and the iShares Biotechnology ETF (NASDAQ:IBB) often treat them as interchangeable proxies for the same sector.

FBT and IBB Are Not the Same Biotech Bet, and 5 Years of Returns Prove It

The Motley Fool

Which Healthcare ETF Is the Better Buy: iShares' Global IXJ or First Trust's Biotech FBT?

iShares Global Healthcare ETF provides broad exposure to 110 global stocks while First Trust NYSE Arca Biotechnology Index Fund concentrates on 30 biotech positions. iShares Global Healthcare ETF carries a lower expense ratio of 0.40% compared to 0.55% for First Trust NYSE Arca Biotechnology Index Fund.

Which Healthcare ETF Is the Better Buy: iShares' Global IXJ or First Trust's Biotech FBT?

The Motley Fool

Which Is the Better Healthcare ETF, First Trust's Biotech-Focused FBT or State Street's Broader XLV?

The State Street Health Care Select Sector SPDR ETF is significantly more affordable and larger than the First Trust NYSE Arca Biotechnology Index Fund, with an expense ratio of 0.08% compared to 0.55%. The First Trust NYSE Arca Biotechnology Index Fund focuses exclusively on biotechnology while the State Street Health Care Select Sector SPDR ETF provides broad exposure across the entire S&P 500 healthcare sector.

Which Is the Better Healthcare ETF, First Trust's Biotech-Focused FBT or State Street's Broader XLV?

The Motley Fool

Biotech ETFs: How Do FBT and IBB Match Up on Cost, Structure, and Performance?

First Trust NYSE Arca Biotechnology Index Fund offers a more concentrated portfolio with only 30 holdings compared to the 248 positions in iShares Biotechnology ETF iShares Biotechnology ETF is the larger and more established fund, having launched in 2001 and managing $9.6 billion in assets under management First Trust NYSE Arca Biotechnology Index Fund has achieved a higher total return over both one-year and five-year horizons

Biotech ETFs: How Do FBT and IBB Match Up on Cost, Structure, and Performance?

See News Rankings

Price charts implemented using Lightweight Charts™